Together, our data show that patients with AD-DLB have more soluble tau oligomers/HMW tau, lower insoluble tau fibrils and an extra intracellular aggregate burden of α-synuclein with the ability to cross-seed endogenous tau. Here, MAPT is linked to Alzheimer disease.